EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events

EMA

15 March 2021 - Several authorities responsible for national vaccine campaigns in EU countries have temporarily paused vaccination with COVID-19 Vaccine AstraZeneca. 

This is a precaution taken in the light of their national situation while EMA investigates a number of events of blood clots in people who had received the vaccine, as previously reported.

 Read EMA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Europe , Vaccine , Safety , COVID-19